Design and structure activity relationships of highly potent and bioavailable imidazolinone FASN KR domain inhibitors

被引:0
|
作者
Bignan, G. [1 ]
Alexander, R. [1 ]
Bischoff, J. [1 ]
Connolly, P. [1 ]
Cummings, M. [1 ]
De Breucker, S. [2 ]
Esser, N. [2 ]
Fraiponts, E. [2 ]
Gilissen, R. [2 ]
Grasberger, B. [1 ]
Janssens, B. [2 ]
Lu, T. [1 ]
Ludovici, D. [1 ]
Meerpoel, L. [2 ]
Meyer, C. [3 ]
Parker, M. [1 ]
Peeters, D. [2 ]
Rocaboy, C. [4 ]
Schubert, C. [1 ]
Smans, K. [2 ]
机构
[1] Janssen, Oncol, Spring House, PA USA
[2] Janssen, Oncol, Beerse, Belgium
[3] Janssen, Oncol, Val De Reuil, France
[4] VillaPharma Res, Chem, Murcia, Spain
关键词
D O I
10.1016/S0959-8049(14)70556-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
430
引用
收藏
页码:141 / 142
页数:2
相关论文
共 50 条
  • [21] De novo design, parallel-syntheses and structure-activity relationships of a series of novel and highly potent neutral inhibitors of factor Xa.
    Huang, WR
    Wang, LY
    Goldman, E
    Zuckett, JF
    Wu, YH
    Woolfrey, J
    Huang, B
    Wong, P
    Sinha, U
    Scarborough, RM
    Zhu, BY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A92 - A92
  • [22] Design and evaluation of dihydroisoquinolines as potent and orally bioavailable human cytomegalovirus inhibitors
    Chan, L
    Stefanac, T
    Turcotte, N
    Hu, ZH
    Chen, YM
    Bédard, J
    May, S
    Jin, HL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (13) : 1477 - 1480
  • [23] Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors
    Hu, Dennis X.
    Patel, Snahel
    Chen, Huifen
    Wang, Shumei
    Staben, Steven T.
    Dimitrova, Yoana N.
    Wallweber, Heidi Ackerly
    Lee, Joanna Y.
    Chan, Grace Ka Yan
    Sneeringer, Christopher J.
    Prangley, Madeleine S.
    Moffat, John G.
    Wu, Kai C.
    Schutt, Leah K.
    Salphati, Laurent
    Pang, Jodie
    McNamara, Erin
    Huang, Haochu
    Chen, Yong
    Wang, Yunli
    Zhao, Wensheng
    Lim, Junghyun
    Murthy, Aditya
    Siu, Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, : 11500 - 11512
  • [24] Novel Highly Potent and Selective Nonsteroidal Aromatase Inhibitors: Synthesis, Biological Evaluation and Structure-Activity Relationships Investigation
    Gobbi, Silvia
    Zimmer, Christina
    Belluti, Federica
    Rampa, Angela
    Hartmann, Rolf W.
    Recanatini, Maurizio
    Bisi, Alessandra
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (14) : 5347 - 5351
  • [25] Structure-based design and discovery of orally bioavailable potent nonbenzamidine factor Xa inhibitors.
    Lam, PYS
    Li, RH
    Clark, CG
    Pinto, DJ
    Alexander, RS
    Rossi, KA
    Knabb, RM
    Wong, PC
    Aungst, BJ
    Bai, SA
    Wright, MR
    Wexler, RR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U31 - U31
  • [26] Design, synthesis, and structure-activity relationships of potent factor Xa inhibitors with benzimidazole as a central template.
    Huang, WR
    Fan, JM
    Jia, ZHJ
    Wong, P
    Tran, K
    Sinha, U
    Scarborough, RM
    Zhu, BY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U130 - U130
  • [27] Design, synthesis, and structure-activity relationships of potent factor Xa inhibitors with benzoxazinone as a central template.
    Huang, WR
    Wang, LY
    Zhang, PL
    Fan, JM
    Wong, P
    Tran, K
    Sinha, U
    Scarborough, RM
    Zhu, BY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U130 - U130
  • [28] Design, Synthesis, and Structure-Activity Relationships of Highly Potent 5-HT3 Receptor Ligands
    Verheij, Mark H. P.
    Thompson, Andrew J.
    van Muijlwijk-Koezen, Jacqueline E.
    Lummis, Sarah C. R.
    Leurs, Rob
    de Esch, Iwan J. P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (20) : 8603 - 8614
  • [29] STRUCTURE-ACTIVITY-RELATIONSHIPS OF ANALOGS OF HIGHLY POTENT OPIOID PEPTIDE BIPHALIN
    MISICKA, A
    LIPKOWSKI, AW
    HORVATH, R
    DAVIS, P
    PORRECA, F
    YAMAMURA, HI
    HRUBY, VJ
    REGULATORY PEPTIDES, 1994, : S131 - S132
  • [30] Potent, Selective, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin Kinase Domain Exhibiting Single Agent Antiproliferative Activity
    Koehler, Michael F. T.
    Bergeron, Philippe
    Blackwood, Elizabeth
    Bowman, Krista K.
    Chen, Yung-Hsiang
    Deshmukh, Gauri
    Ding, Xiao
    Epler, Jennifer
    Lau, Kevin
    Lee, Leslie
    Liu, Lichuan
    Ly, Cuong
    Malek, Shiva
    Nonomiya, Jim
    Oeh, Jason
    Ortwine, Daniel F.
    Sampath, Deepak
    Sideris, Steve
    Trinh, Lan
    Truong, Tom
    Wu, Jiansheng
    Pei, Zhonghua
    Lyssikatos, Joseph P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (24) : 10958 - 10971